Eden Research (LON:EDEN) Trading Down 3.3% – What’s Next?

by · The Cerbat Gem

Eden Research plc (LON:EDEN – Get Free Report)’s stock price traded down 3.3% on Friday . The company traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). 450,985 shares traded hands during trading, a decline of 52% from the average session volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Stock Performance

The company has a quick ratio of 2.42, a current ratio of 3.80 and a debt-to-equity ratio of 1.26. The company has a market cap of £18.56 million, a PE ratio of -12.19 and a beta of 0.92. The stock’s 50 day simple moving average is GBX 3.88 and its two-hundred day simple moving average is GBX 3.95.

Insider Transactions at Eden Research

In other Eden Research news, insider Lykele van der Broek acquired 256,000 shares of the company’s stock in a transaction dated Thursday, February 6th. The stock was bought at an average price of GBX 4 ($0.05) per share, with a total value of £10,240 ($12,975.16). Also, insider Alexander John Abrey acquired 540,540 shares of the company’s stock in a transaction dated Tuesday, January 28th. The stock was acquired at an average cost of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($27,396.86). Company insiders own 14.02% of the company’s stock.

Eden Research Company Profile

(Get Free Report)

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.

Featured Stories